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vABSTRACT
Pure iron (Fe) and its alloys have been recently emphasized as potential 
biodegradable metals due to their good mechanical properties that are close to those 
of stainless steel 316L. This research was focused more on the study of cell-material 
interaction and to analyze the effect of corrosion product on cell behavior by 
performing degradation study. In this study, samples were prepared by coating 
hydroxyapatite (HA) and hydroxyapatite/poly (s-Caprolactone) (HA/PCL) onto 
porous iron using dip coating method. Biosafety and biofunctionality of the sample 
were evaluated by using human skin fibroblast (HSF) and mesenchymal stem (MSC) 
cells. Analysis by Inductively Coupled Plasma- Mass Spectrometry (ICP-MS) 
revealed that concentration of ion Fe was decreased in the medium containing HA- 
coated Fe. However, the weight loss of the sample is high compared to pure porous 
iron and HA/PCL-coated Fe. A positive cell response to the Fe ions was revealed 
during the first 21 days of the cell toxicity study using indirect method. After 21 days 
the HSF cell viability decreased due to acidic eluates and the increase of Fe ions 
concentration that promoted the formation of the reactive oxygen intermediates 
(ROI). From the results obtained, it showed that the HSF and MSC cells exhibited 
higher viability when in contact with the Fe-HA and Fe-PCL/HA than with the Fe 
specimens. However, there is a significant decrease (p<0.05) of cells when cultured 
on three different samples after 3 days of incubation. HA-coated porous Fe also 
provides support for attachment of the cells. Observation under Scanning Electron 
Microscope (SEM) reveals that the filopodia of the mesenchymal stem cells 
preferred to develop onto irregular surface of HA-coated Fe. This study provided 
evidences of a good cell-material interaction on the porous Fe that may confirm the 
feasibility of using porous biodegradable ferum as hard tissue scaffolds.
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ABSTRAK
Ferum tulen dan ferum berasaskan aloi telah dikenal pasti mempunyai potensi 
sebagai material terbiodegradasi kerana ciri mekanikalnya yang seakan-akan 
menyerupai stainless steel 316L. Namun begitu, kadar terdegradasi metal ini 
mengambil tempoh masa yang lama. Dalam kajian ini, sampel ferum yang poros dan 
disaluti dengan hidroksiapatit (HA) serta campuran hidroksiapatit/poly s-kaprolakton 
(HA/PCL) menggunakan kaedah celup penyalutan (dip coating) telah disediakan. 
Hasil analisis menggunakan ICP-MS menunjukkan bahawa kepekatan ion Ferum 
yang diukur dalam medium yang direndam dengan ferum bersalut HA adalah rendah 
walaupun mempunyai pengurangan berat yang ketara berbanding sampel Ferum 
tulen yang poros dan sampel Ferum bersalut HA/PCL. Kajian ketoksisitan sel 
melalui kaedah tidak langsung ke atas ion ferum memberikan respon yang positif 
sehingga 21 hari. Selepas itu, viabiliti sel HSF menunjukkan penyerosotan 
disebabkan oleh elut medium yang berasid dan peningkatan kepekatan ion ferum 
yang menggalakkan pembentukan reactive oxygen intermediate (ROI). Seterusnya, 
ujian biokompatibiliti material dilaksanakan ke atas sel dengan menggunakan sel 
fibroblas manusia (HSF) dan sel stem mesenkimal manusia (MSC). Kedua-dua sel 
ini memberikan peningkatan dalam peratusan viabiliti apabila diuji menggunakan Fe- 
bersalut HA dan Fe-bersalut HA/PCL. Namun begitu, terdapat penurunan yang 
signifikan apabila sel dibiarkan selama tiga hari dengan semua sampel secara 
langsung. Pemerhatian di bawah SEM menunjukkan filopodia sel stem mesenkimal 
lebih mudah berkembang ke atas permukaan tidak rata pada ferum bersalut HA. Hal 
ini membuktikan bahawa sampel tersebut memberikan sokongan yang baik untuk 
pelekatan sel dan mengesahkan kebolehan material ferum terbiodegradasikan yang 
poros sebagai templat (scaffold) untuk tisu keras.
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CHAPTER 1
INTRODUCTION
1.1 Background
In a case of organ function failure, biomedical implant made as a scaffold is 
needed to augment, repair and replace the function of affected tissue for 
reconstruction. The three-dimensional (3-D) scaffold should be porous, have a good 
mechanical strength and able to provide a necessary support for cells to perform its 
function [1]. Recently, biodegradable biomaterials are becoming interesting research 
topics due to its ability to support the healing process of a tissue and subsequently 
degrade on the site of implantation. Thus, degradable material represents a promising 
future in implant studies as they eliminate the risk of secondary surgeries. 
Furthermore, it will reduce the risk of refracture and stress shielding.
Studies on degradable materials such as polymer have shown excellent 
biocompatibility and an optimum degradation rate. However, polymer could not 
withstand a high strength application [2] which makes it less competence to use in 
the orthopaedic sector. Currently, metallic materials such as iron (Fe) and 
magnesium (Mg) have been introduced into the biomedical field and have received
2incredible interest. Iron has mechanical properties similar to bone and its degradation 
product is non-toxic to a human body [3].
Hydroxyapatite (HA) is a well known bioactive ceramics with nearly same 
chemical composition as a human bone. It has excellent biocompatibility and great 
bonding ability with bone structure [4]. However, shaping and implanting HA are 
difficult because of its weak and brittle mechanical properties. The use of HA 
coatings on metallic implants have been reported to stimulate bone healing. During 
the early stage of implantation, the coating shows improvement in the aspect of rate 
and strength of the metallic implant. It would speed up the rehabilitation of patients 
by decreasing the insertion time of implant to final reconstruction [1, 4-7]. To 
overcome the brittleness issue, double coating of HA with poly (s-caprolactone) 
(PCL) were introduced by previous research [8]. Reportedly, the coating will become 
stable and flexible without experiencing crack or delamination compared to the 
hydroxyapatite single coating [8].
The relevant test is necessary to study the biosafety and biofunctionality of 
new devices by biomaterialists. Cell attachment is one of a vital part in determining 
the biocompatibility of a material upon implantation into the human body. This role 
will further gives information on the cell migration, differentiation and proliferation, 
thus making the iron based implant is suitable to be used in bone repair and 
regeneration.
So far, new interest of HA coatings on biodegradable metallic material was 
increasing in recent years. However, the rapid corrosion rate of Mg is the main 
restriction for biomedical application. HA has been shown to have the ability to 
decrease the corrosion rate and improve the bioactivity of Mg alloy [9-10]. Previous 
research demonstrates that coating of iron foam with calcium phosphate/chitosan 
gives mechanically remarkable results as it mimics human bone, which can minimize 
the stress-shielding effects [11]. Therefore, this research is going to be focused more
3on the study of cell-material interaction in porous iron. The porous iron was also 
coated with HA to see its effect on the cell behavior and its degradation study.
1.2 Problem Statement
Iron has been proposed as the potential biodegradable implant due to its 
mechanical properties that are similar to stainless steel. However, even it is 
considered as biocompatible, the range of application is limited by its toxicity at 
maximum concentration [3, 12]. Hydroxyapatite often stated as an osteoconductive 
material because of its ability to support bone tissue progression surrounding the 
implants and to induce fixation via chemical bonding [13]. At this point, this research 
explored the possibility of using iron for bone applications, whereas its bulk was 
minimized by forming porous structure. Hydroxyapatite (HA) and poly (s- 
caprolactone)/hydroxyapatite (PCL/HA) coating was then applied to improve cell 
attachment and growth. HA-coated degradable implant with interconnected pores is 
expected to promote osseointegration without reducing its mechanical properties.
41.3 Objectives
In this study, porous Fe was coated with HA using dip coating, a simple and 
cost effective method. PCL was also used as polymeric binder to improve HA 
coating on the surface of the porous Fe. The cytocompatibility and degradation 
behaviour of those materials were investigated in vitro. Therefore, the objectives of 
this research are as follow:
1) To develop HA-coated porous Fe, HA/PCL-coated porous Fe and evaluate 
their degradation behaviour.
2) To analyse the cell-material interactions on the developed material by a 
series of cytocompatibility testing using two types of different cells; human 
skin fibroblast and human mesenchymal stem cells.
1.4 Significance of Study
Previous studies on iron underlining its degradation behaviour, mechanical 
properties and its biocompatibility have demonstrated its potential to be developed as 
degradable metallic biomaterials. Most of them were performed on solid Fe samples. 
This work was done on porous Fe samples with surface modification. The aims were 
to explore the biocompatibility of porous Fe, the way cells react and attach to the 
surface of the porous Fe structure. In addition, the effect of HA coating was 
investigated based on the behaviour of two different cells.
51.5 Scope of Study
Four scopes have been drawn to achieve the objectives of the research, that is:
1) Preparation of sample, where porous Fe coated with HA and PCL/HA by 
using dip coating method.
2) Characterization of material and coating by using SEM and EDX.
3) Determination of the degradation behaviour by measuring weight change 
and concentration of Fe release during immersion tests in cell culture 
medium.
4) Investigation of the effect of degradation towards cell viability, proliferation 
and morphology by using several assays and microscopic observation.
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